Market News AIOpen the app

Teva's AJOVY® is now on China's list of drugs covered by health insurance.

ProductRead the original at prnewswire.com
Good for TEVA

Teva's AJOVY entered China's 2026 drug reimbursement list, which is expected to improve patient access and ease costs. NeuroGen is Teva's partner in China, and the report gives no sales estimate.

TEVA · Teva Pharmaceutical Industries Ltd.

AI read · Good for TEVA

The AI's read

Lower costs for patients may help more people in China get AJOVY. Teva developed the medicine, but sells it in China through a partnership with NeuroGen. The report gives no estimate of added sales, so the size of the benefit is unknown.

Get alerts for TEVA

Follow Teva Pharmaceutical Industries Ltd. (TEVA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TEVA
Free on the App Store and Google Play, or on the web.